Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo.

Saved in:
Bibliographic Details
Title: Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo.
Authors: Schmidt RJ; Lilly Research Laboratories, Eli Lilly & Company, Cardiovascular Research, 355 Merrill Street, Indianapolis, IN 46285, USA., Beyer TP, Bensch WR, Qian YW, Lin A, Kowala M, Alborn WE, Konrad RJ, Cao G
Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2008 Jun 13; Vol. 370 (4), pp. 634-40. Date of Electronic Publication: 2008 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2104 (Electronic) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1090-2104
DOI:10.1016/j.bbrc.2008.04.004